These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 26846711)

  • 41. Diagnostic value of diffusion-weighted magnetic resonance imaging for local and skull base recurrence of nasopharyngeal carcinoma after radiotherapy.
    Wang C; Liu L; Lai S; Su D; Liu Y; Jin G; Zhu X; Luo N
    Medicine (Baltimore); 2018 Aug; 97(34):e11929. PubMed ID: 30142809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot study.
    Miyazaki K; Jerome NP; Collins DJ; Orton MR; d'Arcy JA; Wallace T; Moreno L; Pearson AD; Marshall LV; Carceller F; Leach MO; Zacharoulis S; Koh DM
    Eur Radiol; 2015 Sep; 25(9):2641-50. PubMed ID: 25773937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging.
    Min Q; Shao K; Zhai L; Liu W; Zhu C; Yuan L; Yang J
    World J Surg Oncol; 2015 Feb; 13():32. PubMed ID: 25889380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic Value of the Pretreatment Primary Lesion Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Nasopharyngeal Carcinoma.
    Qin Y; Yu X; Hou J; Hu Y; Li F; Wen L; Lu Q; Liu S
    Acad Radiol; 2019 Nov; 26(11):1473-1482. PubMed ID: 30772137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging.
    Ahn SS; Shin NY; Chang JH; Kim SH; Kim EH; Kim DW; Lee SK
    J Neurosurg; 2014 Aug; 121(2):367-73. PubMed ID: 24949678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
    Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
    Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early responses assessment of neoadjuvant chemotherapy in nasopharyngeal carcinoma by serial dynamic contrast-enhanced MR imaging.
    Zheng D; Yue Q; Ren W; Liu M; Zhang X; Lin H; Lai G; Chen W; Chan Q; Chen Y
    Magn Reson Imaging; 2017 Jan; 35():125-131. PubMed ID: 27587228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthetic MRI and diffusion-weighted imaging for differentiating nasopharyngeal lymphoma from nasopharyngeal carcinoma: combination with morphological features.
    Zhang H; Hu L; Qin F; Chang J; Zhong Y; Dou W; Hu S; Wang P
    Br J Radiol; 2024 Jun; 97(1159):1278-1285. PubMed ID: 38733577
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravoxel Incoherent Motion Diffusion Weighted Magnetic Resonance Imaging for Differentiation Between Nasopharyngeal Carcinoma and Lymphoma at the Primary Site.
    Yu XP; Hou J; Li FP; Wang H; Hu PS; Bi F; Wang W
    J Comput Assist Tomogr; 2016; 40(3):413-8. PubMed ID: 26953769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Morphological and dynamic contrast enhanced MR imaging features for the differentiation of chordoma and giant cell tumors in the Axial Skeleton.
    Lang N; Su MY; Xing X; Yu HJ; Yuan H
    J Magn Reson Imaging; 2017 Apr; 45(4):1068-1075. PubMed ID: 27490009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Relationship between parameters of dynamic contrast-enhanced MRI and clinical stage of nasopharyngeal carcinoma].
    Yu X; Li F; Hu Y; Lu Q; Wang H
    Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):597-602. PubMed ID: 26714600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
    Dong Y; Liu Q
    J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlations of tumour permeability parameters with apparent diffusion coefficient in nasopharyngeal carcinoma.
    Mui AWL; Lee AWM; Ng WT; Lee VHF; Vardhanabhuti V; Man SSY; Chua DTT; Guan XY
    Phys Imaging Radiat Oncol; 2022 Oct; 24():30-35. PubMed ID: 36148154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffusion and perfusion MRI prediction of progression-free survival in patients with hepatocellular carcinoma treated with concurrent chemoradiotherapy.
    Kim KA; Park MS; Ji HJ; Park JY; Han KH; Kim MJ; Kim KW
    J Magn Reson Imaging; 2014 Feb; 39(2):286-92. PubMed ID: 24302545
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differentiation of olfactory neuroblastomas from nasal squamous cell carcinomas using MR diffusion kurtosis imaging and dynamic contrast-enhanced MRI.
    Xiao Z; Tang Z; Qiang J; Qian W; Zhong Y; Wang R; Wang J; Wu L; Tang W
    J Magn Reson Imaging; 2018 Feb; 47(2):354-361. PubMed ID: 28661554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Usefulness of 3T diffusion-weighted MRI for discrimination of reactive and metastatic cervical lymph nodes in patients with oral squamous cell carcinoma: a pilot study.
    Si J; Huang S; Shi H; Liu Z; Hu Q; Wang G; Shen G; Zhang D
    Dentomaxillofac Radiol; 2014; 43(3):20130202. PubMed ID: 24408820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short-term follow-up MRI after unplanned resection of malignant soft-tissue tumours; quantitative measurements on dynamic contrast enhanced and diffusion-weighted MR images.
    Kim JI; Lee IS; Song YS; Park SK; Choi KU; Song JW
    Br J Radiol; 2016 Oct; 89(1066):20160302. PubMed ID: 27459249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Magnetic Resonance Imaging Features on Deep Learning Algorithm for the Diagnosis of Nasopharyngeal Carcinoma.
    Huang R; Zhou Z; Wang X; Cao X
    Contrast Media Mol Imaging; 2022; 2022():3790269. PubMed ID: 35677026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas.
    Zhong Y; Wang H; Shen Y; Guo A; Wang J; Kang S; Ma L; Pan J; Ye H
    Eur Radiol; 2017 Dec; 27(12):4913-4922. PubMed ID: 28631081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diffusion weighted magnetic resonance imaging of pre and post treatment nasopharyngeal carcinoma.
    Hirshoren N; Damti S; Weinberger J; Meirovitz A; Sosna J; Eliashar R; Eliahou R
    Surg Oncol; 2019 Sep; 30():122-125. PubMed ID: 31500774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.